Market Research Logo

BioCryst Pharmaceuticals Inc (BCRX) - Financial and Strategic SWOT Analysis Review

BioCryst Pharmaceuticals Inc (BCRX) - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

BioCryst Pharmaceuticals Inc (BioCryst) designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. Biocryst integrates disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. The company’s products include peramivir injections, which consists of Rapivab, Alpivab, Rapiacta and Peramiflu for the treatment of Influenza. The company has strategic partnerships with corporate and academic institutes. BioCryst has research operations in Birmingham, Alabama and is headquartered in Durham, North Carolina, the US.

BioCryst Pharmaceuticals Inc Key Recent Developments

Mar 23,2018: Gainey McKenna & Egleston Announces They Have Filed A Class Action Lawsuit Against BioCryst Pharmaceuticals
Mar 22,2018: BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference
Feb 27,2018: BioCryst Announces Fourth Quarter and Full Year 2017 Financial Results
Nov 07,2017: BioCryst Reports Third Quarter 2017 Financial Results
Aug 07,2017: BioCryst Reports Second Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
BioCryst Pharmaceuticals Inc - Key Facts
BioCryst Pharmaceuticals Inc - Key Employees
BioCryst Pharmaceuticals Inc - Key Employee Biographies
BioCryst Pharmaceuticals Inc - Major Products and Services
BioCryst Pharmaceuticals Inc - History
BioCryst Pharmaceuticals Inc - Company Statement
BioCryst Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioCryst Pharmaceuticals Inc - Business Description
BioCryst Pharmaceuticals Inc - Corporate Strategy
BioCryst Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
BioCryst Pharmaceuticals Inc - Strengths
BioCryst Pharmaceuticals Inc - Weaknesses
BioCryst Pharmaceuticals Inc - Opportunities
BioCryst Pharmaceuticals Inc - Threats
BioCryst Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
BioCryst Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 23, 2018: Gainey McKenna & Egleston Announces They Have Filed A Class Action Lawsuit Against BioCryst Pharmaceuticals
Mar 22, 2018: BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference
Nov 07, 2017: BioCryst Reports Third Quarter 2017 Financial Results
Aug 07, 2017: BioCryst Reports Second Quarter 2017 Financial Results
May 30, 2017: Robert A. Ingram Named Chairman of BioCryst Pharmaceuticals
May 04, 2017: BioCryst Reports First Quarter 2017 Financial Results
Feb 27, 2017: BioCryst Reports Fourth Quarter and Full Year 2016 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
BioCryst Pharmaceuticals Inc, Key Facts
BioCryst Pharmaceuticals Inc, Key Employees
BioCryst Pharmaceuticals Inc, Key Employee Biographies
BioCryst Pharmaceuticals Inc, Major Products and Services
BioCryst Pharmaceuticals Inc, History
BioCryst Pharmaceuticals Inc, Other Locations
BioCryst Pharmaceuticals Inc, Subsidiaries
BioCryst Pharmaceuticals Inc, Key Competitors
BioCryst Pharmaceuticals Inc, Ratios based on current share price
BioCryst Pharmaceuticals Inc, Annual Ratios
BioCryst Pharmaceuticals Inc, Annual Ratios (Cont...1)
BioCryst Pharmaceuticals Inc, Interim Ratios
BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
BioCryst Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
BioCryst Pharmaceuticals Inc, Performance Chart (2013 - 2017)
BioCryst Pharmaceuticals Inc, Ratio Charts
BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
BioCryst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report